CD274 and head and neck squamous cell carcinoma: A meta-analysis of 1770 patients across 12 clinical trials, comprising those with solid tumors treated with pembrolizumab (235 HNSCC patients), demonstrated how high TMBs are associated with significantly improved ORR and OS, independent of PD-L1 expression [132].